AGIO
Agios Pharmaceuticals, Inc.Company with tickers: AGIO
CIK
1439222
CUSIP
00847X104
Shares Outstanding
59,471,609
13F Activity (30d)
156 filings
139 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-01-13 | — | |
| 8-K | 2020-01-13 | 2020-01-12 | |
| 8-K | 2020-02-13 | — | |
| 10-K | 2020-02-19 | 2019-12-31 | |
| 10-Q | 2020-04-30 | 2020-03-31 | |
| 8-K | 2020-04-30 | — | |
| 8-K | 2020-05-29 | 2020-05-28 | |
| 8-K | 2020-05-29 | — | |
| 8-K | 2020-06-12 | 2020-06-11 | |
| 8-K | 2020-07-30 | — | |
| 10-Q | 2020-07-30 | 2020-06-30 | |
| 8-K | 2020-09-08 | 2020-09-04 | |
| 8-K | 2020-09-21 | — | |
| 8-K | 2020-11-05 | — | |
| 10-Q | 2020-11-05 | 2020-09-30 | |
| 8-K | 2020-12-01 | — | |
| 8-K | 2020-12-07 | — | |
| 8-K | 2020-12-21 | — | |
| 8-K | 2020-12-22 | 2020-12-20 | |
| 8-K | 2021-01-11 | — | |
| 8-K | 2021-01-26 | — | |
| 8-K | 2021-01-29 | — | |
| 8-K | 2021-02-25 | — | |
| 10-K | 2021-02-25 | 2020-12-31 | |
| 8-K | 2021-03-15 | — | |
| 8-K | 2021-03-25 | — | |
| 8-K | 2021-04-02 | 2021-03-31 | |
| 8-K | 2021-04-06 | 2021-03-31 | |
| 8-K | 2021-04-29 | — | |
| 10-Q | 2021-04-29 | 2021-03-31 | |
| 10-Q/A | 2021-05-07 | 2021-03-31 | |
| 8-K | 2021-05-21 | 2021-05-20 | |
| 8-K | 2021-06-11 | — | |
| 8-K | 2021-06-21 | 2021-06-15 | |
| 10-Q | 2021-07-29 | 2021-06-30 | |
| 8-K | 2021-07-29 | 2021-07-27 | |
| 8-K | 2021-08-04 | 2021-08-01 | |
| 10-Q | 2021-11-03 | 2021-09-30 | |
| 8-K | 2021-11-03 | — | |
| 8-K | 2022-01-14 | — | |
| 8-K | 2022-02-24 | — | |
| 10-K | 2022-02-24 | 2021-12-31 | |
| 8-K | 2022-04-26 | 2022-04-25 | |
| 10-Q | 2022-05-05 | 2022-03-31 | |
| 8-K | 2022-05-05 | — | |
| 8-K | 2022-05-18 | 2022-05-15 | |
| 8-K | 2022-05-26 | 2022-05-23 | |
| 8-K | 2022-06-22 | 2022-06-21 | |
| 8-K | 2022-07-12 | 2022-07-07 | |
| 10-Q | 2022-08-04 | 2022-06-30 |
Showing 1–50 of 103 filings